ICD 9 CM Codes

201.40 Hodgkin's disease, lymphocytic-histiocytic predominance, unspecified site, extranodal and solid organ sites
POA Exempt
Billable CodeICD-9-CM  201.40    is a billable medical code that can be used to specify a diagnosis on a reimbursement claim.
ICD-9-CM '201.40' will be replaced by an equivalent ICD-10-CM code (or codes) when the United States transitions from ICD-9-CM to ICD-10-CM on October 1, 2015.
GEMS
201.40 direcly converts to ICD-10-CM
ICD-10-CM C81.00 Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site
GEMS
201.40 direcly converts to ICD-10-CM
ICD-10-CM C81.09 Nodular lymphocyte predominant Hodgkin lymphoma, extranodal and solid organ sites
GEMS
201.40 direcly converts to ICD-10-CM
ICD-10-CM C81.40 Lymphocyte-rich classical Hodgkin lymphoma, unspecified site
GEMS
201.40 direcly converts to ICD-10-CM
ICD-10-CM C81.49 Lymphocyte-rich classical Hodgkin lymphoma, extranodal and solid organ sites
ICD-9-CM codes are used in medical billing and coding to describe diseases, injuries, symptoms and conditions. ICD-9-CM 201.40 is one of thousands of ICD-9-CM codes used in healthcare. Although ICD-9-CM and CPT codes are largely numeric, they differ in that CPT codes describe medical procedures and services. Can't find a code? Start at the root of ICD-9-CM, check the 2015 ICD-9-CM Index or use the search engine at the top of this page to lookup any code.